Sale!

WT1 Gene Wilms tumor type 1 familial Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The WT1 Gene Wilms Tumor Type 1 Familial Genetic Test is a sophisticated diagnostic procedure designed to detect mutations in the WT1 gene, which is crucial for early identification and management of Wilms tumor, a type of kidney cancer predominantly affecting children. This test is particularly vital for individuals with a family history of Wilms tumor, as it helps in determining their risk of developing the disease. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is 4400 AED, an investment towards personalized healthcare and preventive strategies for at-risk families. By identifying genetic mutations early, this test plays a key role in guiding clinical decisions, including surveillance and preventive measures, to improve outcomes and quality of life for those affected.

Description

WT1 Gene Wilms tumor type 1 familial Genetic Test

Test Name: WT1 Gene Wilms tumor type 1 familial Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for WT1 Gene Wilms tumor type 1, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WT1 Gene Wilms tumor type 1, familial NGS Genetic DNA Test gene WT1

Test Details: The WT1 gene, also known as Wilms tumor type 1 gene, is a tumor suppressor gene that plays a crucial role in normal kidney development. Mutations in the WT1 gene have been associated with the development of Wilms tumor, a type of kidney cancer that primarily affects children. Familial NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations or variations in genes associated with hereditary diseases or conditions. In the case of WT1 gene testing, it is used to detect any mutations or variations in the WT1 gene that may increase the risk of developing Wilms tumor within families. By analyzing the DNA sequence of the WT1 gene, NGS genetic testing can identify specific mutations or variations that may be present in an individual’s genetic code. This information can help in determining the likelihood of developing Wilms tumor and can guide appropriate medical management and surveillance for individuals at risk. It is important to note that familial NGS genetic testing for the WT1 gene is typically recommended for individuals with a family history of Wilms tumor or other associated conditions. The test is usually performed on a blood or saliva sample, and the results are interpreted by genetic counselors or healthcare professionals with expertise in genetic testing and counseling. If you have concerns about Wilms tumor or a family history of the condition, it is recommended to consult with a healthcare provider or a genetic counselor who can provide more information and guidance regarding WT1 gene testing and its implications.

Test Name	WT1 Gene Wilms tumor type 1 familial Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hepatology Nephrology Endocrinology Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for WT1 Gene Wilms tumor type 1, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with WT1 Gene Wilms tumor type 1, familial NGS Genetic DNA Test gene WT1
Test Details	The WT1 gene, also known as Wilms tumor type 1 gene, is a tumor suppressor gene that plays a crucial role in normal kidney development. Mutations in the WT1 gene have been associated with the development of Wilms tumor, a type of kidney cancer that primarily affects children. Familial NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations or variations in genes associated with hereditary diseases or conditions. In the case of WT1 gene testing, it is used to detect any mutations or variations in the WT1 gene that may increase the risk of developing Wilms tumor within families. By analyzing the DNA sequence of the WT1 gene, NGS genetic testing can identify specific mutations or variations that may be present in an individual’s genetic code. This information can help in determining the likelihood of developing Wilms tumor and can guide appropriate medical management and surveillance for individuals at risk. It is important to note that familial NGS genetic testing for the WT1 gene is typically recommended for individuals with a family history of Wilms tumor or other associated conditions. The test is usually performed on a blood or saliva sample, and the results are interpreted by genetic counselors or healthcare professionals with expertise in genetic testing and counseling. If you have concerns about Wilms tumor or a family history of the condition, it is recommended to consult with a healthcare provider or a genetic counselor who can provide more information and guidance regarding WT1 gene testing and its implications.